Your browser doesn't support javascript.
loading
Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome.
Billon, Clarisse; Adham, Salma; Hernandez Poblete, Natalia; Legrand, Anne; Frank, Michael; Chiche, Laurent; Zuily, Stephane; Benistan, Karelle; Savale, Laurent; Zaafrane-Khachnaoui, Khaoula; Brehin, Anne-Claire; Bal, Laurence; Busa, Tiffany; Fradin, Mélanie; Quelin, Chloé; Chesneau, Bertrand; Wahl, Denis; Fergelot, Patricia; Goizet, Cyril; Mirault, Tristan; Jeunemaitre, Xavier; Albuisson, Juliette.
Afiliação
  • Billon C; Département de génétique, Centre national de référence pour les maladies vasculaires rares, centre de référence européen VASCERN MSA, Hôpital Européen Georges Pompidou, AP-HP, 20 rue Leblanc, 75015, Paris, France. clarisse.billon@aphp.fr.
  • Adham S; INSERM, U970 PARCC, Université de Paris, Paris, France. clarisse.billon@aphp.fr.
  • Hernandez Poblete N; Département de génétique, Centre national de référence pour les maladies vasculaires rares, centre de référence européen VASCERN MSA, Hôpital Européen Georges Pompidou, AP-HP, 20 rue Leblanc, 75015, Paris, France.
  • Legrand A; Service de Médecine Vasculaire, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France.
  • Frank M; Département de génétique médicale, Centre national de référence pour les maladies rares Neurogénétiques, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
  • Chiche L; Laboratoire de maladies rares : Génétique et Metabolisme (MRGM), INSERM U1211, Université de Bordeaux, Bordeaux, France.
  • Zuily S; Département de génétique, Centre national de référence pour les maladies vasculaires rares, centre de référence européen VASCERN MSA, Hôpital Européen Georges Pompidou, AP-HP, 20 rue Leblanc, 75015, Paris, France.
  • Benistan K; INSERM, U970 PARCC, Université de Paris, Paris, France.
  • Savale L; Département de génétique, Centre national de référence pour les maladies vasculaires rares, centre de référence européen VASCERN MSA, Hôpital Européen Georges Pompidou, AP-HP, 20 rue Leblanc, 75015, Paris, France.
  • Zaafrane-Khachnaoui K; INSERM, U970 PARCC, Université de Paris, Paris, France.
  • Brehin AC; Faculté de médecine, Université de la Sorbonne, Paris, France.
  • Bal L; Service de chirurgie vasculaire et endovasculaire, Centre aortique tertiaire, Hôpital universitaire Pitié-Salpêtrière, AP-HP, Paris, France.
  • Busa T; Inserm UMRS 1116 DCAC, Université de Lorraine, Nancy, France.
  • Fradin M; Division de médecine vasculaire et centre de compétence régional pour les maladies vasculaires rares et autoimmunes systémiques, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.
  • Quelin C; Centre de Référence des Syndromes d'Ehlers-Danlos non Vasculaires, Hôpital Raymond Poincaré, Assistance Publique Hôpitaux de Paris, Garches, France.
  • Chesneau B; UMR U1179 INSERM, Université Versailles Saint-Quentin, Montigny-le-Bretonneux, France.
  • Wahl D; Université Paris-Saclay, Le Kremlin Bicêtre, France.
  • Fergelot P; UMR_S 999, INSERM, Groupe hospitalier Marie-Lannelongue -Saint Joseph, Université Paris-Sud, Le Plessis-Robinson, France.
  • Goizet C; Service de Pneumologie, Hôpital Bicêtre, APHP, Le Kremlin-Bicêtre, France.
  • Mirault T; Unité de génétique médicale 2, Hôpital L'Archet, Nice, France.
  • Jeunemaitre X; INSERM U1245 , Normandy center for Genomic and Personalized Medicine, Normandie Univ, CHU Rouen, 76000, Rouen, France.
  • Albuisson J; Centre de référence régional Marfan et apparentés, Centre aortique, Hôpital La Timone, AP-HM, Marseille, France.
Orphanet J Rare Dis ; 16(1): 504, 2021 12 04.
Article em En | MEDLINE | ID: mdl-34863227
ABSTRACT

BACKGROUND:

FLNA Loss-of-Function (LoF) causes periventricular nodular heterotopia type 1 (PVNH1), an acknowledged cause of seizures of various types. Neurological symptoms are inconstant, and cardiovascular (CV) defects or connective tissue disorders (CTD) have regularly been associated. We aimed at refining the description of CV and CTD features in patients with FLNA LoF and depicting the multisystemic nature of this condition.

METHODS:

We retrospectively evaluated FLNA variants and clinical presentations in FLNA LoF patient with at least one CV or CTD feature, from three cohorts ten patients from the French Reference Center for Rare Vascular Diseases, 23 patients from the national reference diagnostic lab for filaminopathies-A, and 59 patients from literature review.

RESULTS:

Half of patients did not present neurological symptoms. Most patients presented a syndromic association combining CV and CTD features. CV anomalies, mostly aortic aneurysm and/or dilation were present in 75% of patients. CTD features were present in 75%. Variants analysis demonstrated an enrichment of coding variants in the CH1 domain of FLNA protein.

CONCLUSION:

In FLNA LoF patients, the absence of seizures should not be overlooked. When considering a diagnosis of PVNH1, the assessment for CV and CTD anomalies is of major interest as they represent interlinked features. We recommend systematic study of FLNA within CTD genes panels, regardless of the presence of neurological symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Tecido Conjuntivo / Heterotopia Nodular Periventricular Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Tecido Conjuntivo / Heterotopia Nodular Periventricular Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França